A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Clinical trial NCT04722146 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04722146
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2025-10-03
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.